Saturday, November 23, 2024
HomeTagsREMaster technology platform

REMaster technology platform

Remix Therapeutics Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer

Remix Therapeutics, a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced the appointment of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics